Mostrar el registro sencillo del ítem

dc.contributor.authorCruz López, Olga 
dc.contributor.authorRamirez, Alberto
dc.contributor.authorNavarro Marchal, Saul Abenhamar 
dc.contributor.authorGarcía, María A
dc.contributor.authorMarchal Corrales, Juan Antonio 
dc.contributor.authorCampos Rosa, Joaquín María 
dc.contributor.authorConejo García, Ana 
dc.date.accessioned2024-02-01T12:20:54Z
dc.date.available2024-02-01T12:20:54Z
dc.date.issued2017
dc.identifier.urihttps://hdl.handle.net/10481/87935
dc.description.abstractAim: Bozepinib is a potent and selective anticancer compound which chemical structure is made up of a benzofused seven-membered ring and a purine moiety. We previously demonstrated that the purine fragment does not exert antiproliferative effect per se. Methodology: A series of 1-(benzenesulfonyl)-4,1-benzoxazepine derivatives were synthesized in order to study the influence of the benzofused seven-membered ring in the biological activity of bozepinib by means of antiproliferative, cell cycle and apoptosis studies. Results & conclusion: Our results show that the methyleneoxy enamine sulfonyl function is essential in the antitumor activity of the structures and thus, it is a scaffold suitable for further modification with a view to obtain more potent antitumor compounds.es_ES
dc.language.isoenges_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.title1-(Benzenesulfonyl)-1,5-dihydro-4,1-benzoxazepine as a new scaffold for the design of antitumor compoundses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.4155/fmc-2017-0006


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional